Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease

When angiotensin-converting enzyme inhibitor/angiotensin receptor blocker-treated patients present with SARS-CoV-2 infection there is a debate to know whether renin-angiotensin-aldosterone (RAAS) blockers should be stopped or not. We conducted a prospective observational study in Bulgarian COVID-19-...

Descripción completa

Detalles Bibliográficos
Autores principales: Filev, Rumen, Rostaing, Lionel, Lyubomirova, Mila, Bogov, Boris, Kalinov, Krassimir, Svinarov, Dobrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726321/
https://www.ncbi.nlm.nih.gov/pubmed/36482641
http://dx.doi.org/10.1097/MD.0000000000031988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726321/
https://www.ncbi.nlm.nih.gov/pubmed/36482641
http://dx.doi.org/10.1097/MD.0000000000031988

Ejemplares similares